US pharmaceutical company Merck said Friday it will seek authorization of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent.
Oct 1, 2021
0
37
Current knowledge about Parkinson's disease (PD) does not reflect the diversity of people with the disease, according to The Michael J. Fox Foundation for Parkinson's Research (MJFF). In a position paper published in the ...
Oct 1, 2021
0
0
Pharmacogenomics, the study of how a person's unique genetic makeup—their genome—influences their response to medications, has become the cornerstone of precision medicine. In a review of the current state of the field ...
Sep 15, 2021
0
24
A person's genetics may hold the key to early intervention in cardiovascular disease, leading to better outcomes in patient care. Researchers at Baylor College of Medicine's Human Genome Sequencing Center and Baylor cardiologists ...
Aug 9, 2021
0
158
Scientists in Cancer Sciences have published findings of their research into how two important antibody drugs work and why they sometimes fail in some patients.
Aug 2, 2021
0
6
Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks, play a large part in heart diseases and the necrosis of cardiac tissue after blood supply is decreased or stopped.
Jul 27, 2021
0
9
In the largest study of its kind, an investigation by UC San Francisco has found no evidence that moderate coffee consumption can cause cardiac arrhythmia.
Jul 20, 2021
0
66
The latest investigations into a promising new genetic test for glaucoma—the leading cause of blindness worldwide—has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing ...
Jul 15, 2021
0
4
A team led by researchers at Baylor College of Medicine found that a screening method known as untargeted metabolomics profiling can improve the diagnostic rate for inborn errors of metabolism, a group of rare genetic conditions, ...
Jul 12, 2021
0
4
A novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. The study, led by researchers at The Ohio State University ...
Jul 12, 2021
0
46
